181 related articles for article (PubMed ID: 32151015)
21. Ciclopirox and Efinaconazole Transungual Permeation, Antifungal Activity, and Proficiency To Induce Resistance in Trichophyton rubrum.
Monti D; Mazzantini D; Tampucci S; Vecchione A; Celandroni F; Burgalassi S; Ghelardi E
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332076
[TBL] [Abstract][Full Text] [Related]
22. Onychomycosis: Potential of Nail Lacquers in Transungual Delivery of Antifungals.
Akhtar N; Sharma H; Pathak K
Scientifica (Cairo); 2016; 2016():1387936. PubMed ID: 27123362
[TBL] [Abstract][Full Text] [Related]
23. Application of central composite design for the optimization of itraconazole loaded nail lacquer formulation.
Rahman A; Aqil M; Ahad A; Imam SS; Qadir A; Ali A
3 Biotech; 2021 Jul; 11(7):324. PubMed ID: 34194908
[TBL] [Abstract][Full Text] [Related]
24. Ciclopirox Hydroxypropyl Chitosan (CPX-HPCH) Nail Lacquer and Breathable Cosmetic Nail Polish: In Vitro Evaluation of Drug Transungual Permeation Following the Combined Application.
Monti D; Tampucci S; Paganini V; Burgalassi S; Chetoni P; Galván J; Celandroni F; Ghelardi E
Life (Basel); 2022 May; 12(6):. PubMed ID: 35743832
[TBL] [Abstract][Full Text] [Related]
25. Ciclopirox delivery into the human nail plate.
Hui X; Wester RC; Barbadillo S; Lee C; Patel B; Wortzmman M; Gans EH; Maibach HI
J Pharm Sci; 2004 Oct; 93(10):2545-8. PubMed ID: 15349963
[TBL] [Abstract][Full Text] [Related]
26. Hydroxypropyl chitosan nail lacquer of ciclopirox-PLGA nanocapsules for augmented in vitro nail plate absorption and onychomycosis treatment.
Gaballah EY; Borg TM; Mohamed EA
Drug Deliv; 2022 Dec; 29(1):3304-3316. PubMed ID: 36372978
[TBL] [Abstract][Full Text] [Related]
27. In-vitro permeability of the human nail and of a keratin membrane from bovine hooves: penetration of chloramphenicol from lipophilic vehicles and a nail lacquer.
Mertin D; Lippold BC
J Pharm Pharmacol; 1997 Mar; 49(3):241-5. PubMed ID: 9231338
[TBL] [Abstract][Full Text] [Related]
28. A Preliminary Investigation of Additive Manufacture to Fabricate Human Nail Plate Surrogates for Pharmaceutical Testing.
Sil BC; Patel A; Crowther JM; Moore DJ; Hadgraft J; Hilton ST; Lane ME
Pharmaceutics; 2019 May; 11(6):. PubMed ID: 31141993
[TBL] [Abstract][Full Text] [Related]
29. A drug-in-adhesive anti-onychomycotic nail patch: Influence of drug and adhesive nature on drug release, ungual permeation, in vivo residence in human and anti-fungal efficacy.
Rizi K; Xu K; Begum T; Faull J; Bhakta S; Murdan S
Int J Pharm; 2022 Feb; 614():121437. PubMed ID: 34973408
[TBL] [Abstract][Full Text] [Related]
30. Ciclopirox nail lacquer for the treatment of onychomycosis: an open non-comparative study.
Shemer A; Nathansohn N; Trau H; Amichai B; Grunwald MH
J Dermatol; 2010 Feb; 37(2):137-9. PubMed ID: 20175847
[TBL] [Abstract][Full Text] [Related]
31. An innovative water-soluble biopolymer improves efficacy of ciclopirox nail lacquer in the management of onychomycosis.
Baran R; Tosti A; Hartmane I; Altmeyer P; Hercogova J; Koudelkova V; Ruzicka T; Combemale P; Mikazans I
J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):773-81. PubMed ID: 19453778
[TBL] [Abstract][Full Text] [Related]
32. Competitive displacement of drugs from cyclodextrin inclusion complex by polypseudorotaxane formation with poloxamer: implications in drug solubilization and delivery.
Nogueiras-Nieto L; Sobarzo-Sánchez E; Gómez-Amoza JL; Otero-Espinar FJ
Eur J Pharm Biopharm; 2012 Apr; 80(3):585-95. PubMed ID: 22182528
[TBL] [Abstract][Full Text] [Related]
33. Ciclopirox vs amorolfine: in vitro penetration into and permeation through human healthy nails of commercial nail lacquers.
Monti D; Tampucci S; Chetoni P; Burgalassi S; Mailland F
J Drugs Dermatol; 2014 Feb; 13(2):143-7. PubMed ID: 24509963
[TBL] [Abstract][Full Text] [Related]
34. Emergence of nail lacquers as potential transungual delivery system in the management of onchomycosis.
Kataria P; Sharma G; Thakur K; Bansal V; Dogra S; Katare OP
Expert Opin Drug Deliv; 2016 Jul; 13(7):937-52. PubMed ID: 27054394
[TBL] [Abstract][Full Text] [Related]
35. New Formulation-Microporation Combination Approaches to Delivering Ciclopirox across Human Nails.
Kishishita J; de Almeida Perez Pimenta C; Cerqueira Macedo DP; Delgado-Charro MB; Bastos Leal L
Pharmaceutics; 2024 Jan; 16(1):. PubMed ID: 38258083
[TBL] [Abstract][Full Text] [Related]
36. Transungual Delivery, Anti-Inflammatory Activity, and In Vivo Assessment of a Cyclodextrin Polypseudorotaxanes Nail Lacquer.
Fernández-Campos F; Navarro F; Corrales A; Picas J; Pena E; González J; Otero-Espinar FJ
Pharmaceutics; 2020 Aug; 12(8):. PubMed ID: 32759698
[TBL] [Abstract][Full Text] [Related]
37. Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
Gupta AK
J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S81-95. PubMed ID: 11051137
[TBL] [Abstract][Full Text] [Related]
38. Development of topical therapeutics for management of onychomycosis and other nail disorders: a pharmaceutical perspective.
Elsayed MM
J Control Release; 2015 Feb; 199():132-44. PubMed ID: 25481439
[TBL] [Abstract][Full Text] [Related]
39. Ciclopirox nail lacquer 8%: in vivo penetration into and through nails and in vitro effect on pig skin.
Ceschin-Roques CG; Hänel H; Pruja-Bougaret SM; Luc J; Vandermander J; Michel G
Skin Pharmacol; 1991; 4(2):89-94. PubMed ID: 1831626
[TBL] [Abstract][Full Text] [Related]
40. Bilayered nail lacquer of terbinafine hydrochloride for treatment of onychomycosis.
Shivakumar HN; Vaka SR; Madhav NV; Chandra H; Murthy SN
J Pharm Sci; 2010 Oct; 99(10):4267-76. PubMed ID: 20737634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
